We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





No-Touch, Paper-Based COVID-19 Diagnostic Test Could Detect SARS-CoV-2 Using Electrical Frequencies

By LabMedica International staff writers
Posted on 06 Aug 2020
Researchers from the Iowa State University (Ames, IA, USA) are developing a closed, contact-free diagnostic sensing system that could be used to quickly test for COVID-19 or other outbreaks.

The researchers aim to develop a low-cost, mail-safe, fast-scan “diagnostic platform that is well-suited for widespread monitoring of infection during pandemics. More...
The USD 1 (or so) COVID-19 diagnostic test kit would allow anyone to take their own nasal and cough samples. The samples would be spread on a card which can be stuffed in an envelope with a virus-killing coating and allowed to incubate overnight. The envelope can then be dropped at a collection center or in the mail. The unopened envelope would be scanned by an electronic reader to determine a positive or negative result. Then, that never-opened envelope, samples and all, would be dropped in an incinerator. The electronic reader would automatically text or email the results to the sender.

The key to the technology is a new sensor system based on “toehold switches” that detect target RNA genetic material. That detection triggers production of “reporter” proteins that can change the color of a sensor or, in this case, the frequency of a sensor’s signal. The finished product would involve a multilayered assembly on thick paper. The top layer would hold collected nasal or cough samples, the middle layers would contain the toehold switch, and the bottom layers would have a printed, coiled resonant circuit that can be scanned for telltale frequencies. If there’s target COVID-19 RNA in the samples, the toehold switch would allow production of proteins that degrade a coating on the circuit resulting in a positive signal. If there’s no virus RNA, there’s no protein production, no coating degradation and a negative signal.

The approach would reduce the burden of diagnostics from health workers, eliminate the increased use of limited personal protective equipment, and provide a better response to outbreaks. It would also provide a real-time outbreak map with demographic details to help public health officials monitor the infection. Additionally, the technology can be tuned to detect other diseases or even future pandemics.

“We’re trying to make it so that no one has to touch the samples,” said Nigel Reuel, an assistant professor of chemical and biological engineering at Iowa State University. “The driving motivation of this project is to provide a faster response to enable widespread screening and tracking of an expanding viral outbreak.”

Related Links:
Iowa State University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Homocysteine Quality Control
Liquichek Homocysteine Control
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.